These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 27620503)

  • 1. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A; Wang S; Zhang J; Wu H
    Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells.
    Zhang X; Sun J; Xin W; Li Y; Ni L; Ma X; Zhang D; Zhang D; Zhang T; Du G
    Int Immunopharmacol; 2015 Mar; 25(1):88-95. PubMed ID: 25637446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
    San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
    Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
    Tian L; Li W; Wang T
    Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
    Liu X; Jin X; Yu D; Liu G
    Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
    Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
    Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
    Wang C; Zeng L; Zhang T; Liu J; Wang W
    Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
    Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
    Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
    Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
    J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
    Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
    Shen Y; Sun Z; Guo X
    Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
    Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
    Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
    Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
    Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
    Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
    Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
    J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.